Puylaert Kevin's Form 4 filing
SOPHiA GENETICS SA (SOPH) · filed Apr 8, 2026
- Accession no.
- 0001840706-26-000127
- Filed
- Apr 8, 2026
- Trade date
- Apr 6, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $3.03K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Puylaert KevinCIK 0002119354 | Officer (Chief Sales Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 6, 2026 | Ordinary Shares | SSaleDisposed | −548 | $4.86 | −$2,663.28 | 148,306 | Direct | |
| Apr 6, 2026 | Ordinary Shares | SSaleDisposed | −46 | $4.86 | −$223.56 | 148,260 | Direct | |
| Apr 6, 2026 | Ordinary Shares | SSaleDisposed | −30 | $4.83 | −$144.9 | 148,230 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.